Provided by Tiger Trade Technology Pte. Ltd.

Capricor Therapeutics

6.29
-0.5450-7.97%
Post-market: 6.380.0900+1.43%19:59 EDT
Volume:8.36M
Turnover:53.59M
Market Cap:365.69M
PE:-2.55
High:7.08
Open:6.81
Low:6.01
Close:6.84
52wk High:40.37
52wk Low:2.96
Shares:58.14M
Float Shares:45.54M
Volume Ratio:0.38
T/O Rate:18.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4659
EPS(LYR):-2.2601
ROE:-73.70%
ROA:-33.63%
PB:1.49
PE(LYR):-2.78

Loading ...

Capricor Therapeutics Price Target Maintained With a $60.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 10

Capricor Therapeutics Stock Jumps As FDA Resumes Deramiocel Review

Benzinga_recent_news
·
Mar 10

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT) and Capricor Therapeutics (CAPR)

TIPRANKS
·
Mar 10

BUZZ-Capricor surges as FDA resumes review of muscle‑wasting disease drug

Reuters
·
Mar 10

Capricor announces establishment of new PDUFA date for dermiocel BLA

TIPRANKS
·
Mar 10

Capricor Shares Rise 11% After FDA Resumes Review of Co's Drug for Muscle-Wasting Condition

THOMSON REUTERS
·
Mar 10

FDA sets Aug. 22, 2026 PDUFA date for Capricor’s deramiocel BLA after lifting CRL

Reuters
·
Mar 10

Capricor Therapeutics Inc - Pdufa Target Action Date for Deramiocel Set for August 22, 2026

THOMSON REUTERS
·
Mar 10

Capricor Therapeutics Inc - Expects Eligibility for Priority Review Voucher Upon Deramiocel Approval

THOMSON REUTERS
·
Mar 10

Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA

GlobeNewswire
·
Mar 10

What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday?

Benzinga
·
Mar 10

BUZZ-U.S. STOCKS ON THE MOVE-Biotechs, Agilent, Dow

Reuters
·
Mar 09

BUZZ-Biotechs gain as FDA vaccines chief's exit seen as easing regulatory pathway

Reuters
·
Mar 09

Capricor Therapeutics to Present Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Update on March 12

GlobeNewswire
·
Mar 09

BUZZ-Uniqure jumps after FDA vaccines chief Vinay Prasad to step down

Reuters
·
Mar 07

MAHA Is Bringing Chaos to Biotech Investment Beyond Just Vaccines -- Heard on the Street -- WSJ

Dow Jones
·
Mar 03

Capricor Therapeutics to Present Late-Breaking Phase 3 HOPE-3 Deramiocel Data at MDA Clinical and Scientific Conference

Reuters
·
Feb 24